CS logo
small CS logo
ATI

Bolingbrook, Illinois, United States

About ATI


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at ATI


During the past decade, ATI conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators



Clinical Trials Conditions at ATI


According to Clinical.Site data, the most researched conditions in "ATI" are "Carpal Tunnel Syndrome" (1 trials), "Fracture" (1 trials), "Hip Osteoarthritis" (1 trials), "Knee Osteoarthritis" (1 trials) and "Osteoarthritis" (1 trials). Many other conditions were trialed in "ATI" in a lesser frequency.

Clinical Trials Intervention Types at ATI


Most popular intervention types in "ATI" are "Diagnostic Test" (1 trials). Other intervention types were less common.
The name of intervention was led by "Screening and diagnosis if injured" (1 trials). Other intervention names were less common.

Clinical Trials Genders at ATI


The vast majority of trials in "ATI" are 2 trials for "All" genders.

Clinical Trials Status at ATI


Currently, there are NaN active trials in "ATI". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were undefined completed trials in ATI, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in ATI, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".